Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Kwangdong Pharmaceutical Co. Ltd.

www.ekdp.com

Latest From Kwangdong Pharmaceutical Co. Ltd.

Asia Deal Watch: Bharat Expands Its Vaccine Holdings By Buying GSK’s Chiron Behring

Bharat hopes to expand international reach of Chiron Behring’s rabies vaccine. WuXi and Biolingus partner on sublingual delivery.

Commercial Deals

Asia Deal Watch: BIOCAD, Shanghai Pharma Agree On Pair Of Russian/Chinese Joint Ventures

The JVs will develop and commercialize therapeutics for multiple cancer types and autoimmune disorders in China. Novocure partners its Tumor Treating Fields technology with Zai Lab, while Fate and ONO will collaborate on off-the-shelf CAR-T therapies.

Asia Pacific Deals

Deals Shaping The Medical Industry, December 2017

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance or Financing. This month’s column covers deals announced in November 2017.

Deals BioPharmaceutical

Deal Watch: Ionis Out-Licenses Pair Of Generation 2.5 Antisense Candidates

Janssen and French biotech Dynacure take licenses to antisense candidates arising from Ionis’ Generation 2.5 technology. Merck and Cue sign autoimmune partnership, while Bayer and PeptiDream ink discovery pact.

Deals M & A
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Nutraceuticals
    • OTC, Consumer
  • Therapeutic Areas
  • Cancer
  • Cardiovascular
  • Gynecological, Urological
  • Metabolic Disorders
  • Neurology, Nervous System
  • Ophthalmic
  • Respiratory, Pulmonary
  • Alias(es)
  • Kwang Dong Pharmaceutical Co. Ltd.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Asia
      • Pacific Rim
        • South Korea
  • Parent & Subsidiaries
  • Kwangdong Pharmaceutical Co. Ltd.
  • Senior Management
  • Sung Won Choi, Pres. & CEO
  • Contact Info
  • Kwangdong Pharmaceutical Co. Ltd.
    Phone: (82) 2-6006-7777
    85, Seochojungang-ro
    Seocho-gu, 137-875
    South Korea
Advertisement
Advertisement
UsernamePublicRestriction

Register